Most Read Articles
30 Apr 2017
New drug applications approved by US FDA as of 16 - 30 April 2017 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.

Venous Thromboembolism (VTE) Prophylaxis in Postpartum: Translating Evidence into Practice

26 Sep 2016
At the 24th Congress of the Obstetrical & Gynaecological Society of Malaysia, Dr Harris N Suharjono highlighted the importance of VTE prophylaxis in postpartum and discussed the challenges and actions taken following the implementation of the Sarawak Obstetric VTE Risk Assessment Programme.

Related MIMS Drugs

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS JPOG - Malaysia digital copy today!
DOWNLOAD
Editor's Recommendations
Most Read Articles
30 Apr 2017
New drug applications approved by US FDA as of 16 - 30 April 2017 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.